Doxorubicin in relapsed soft tissue sarcoma: justification of phase II evaluation of new drugs in this disease. An EORTC Soft Tissue and Bone Sarcoma Group Study.
作者信息
Blackledge G, van Oosterom A, Mouridsen H, Steward W P, Buesa J, Thomas D, Sylvester R, Rouesse J
机构信息
Department of Medicine, Queen Elizabeth Hospital, Birmingham, U.K.
出版信息
Eur J Cancer. 1990 Feb;26(2):139-41. doi: 10.1016/0277-5379(90)90296-6.
PMID:2138908
Abstract
摘要
Zotero 插件